MERZ on the Move: Days After Ulthera Acquisition, Company Announces Plans for New Retinoid Therapy
Days after Ulthera acquisition, company announces plans to develop new Retinoid Therapy with Brickell Biotech.
Days after Ulthera acquisition, company announces plans to develop new Retinoid Therapy with Brickell Biotech.
For patients considering or undergoing plastic and reconstructive surgery procedures, using social media to gather information and answer questions can enhance patient empowerment—potentially leading to increased autonomy and better decision-making, reports a study in the April issue of Plastic and Reconstructive Surgery.